Clinical Trial

Denosumab helps postmenopausal women reach bone density goals.

This clinical trial examines the probability of postmenopausal women with osteoporosis achieving bone mineral density treatment goals with denosumab. The study highlights that achieving a T-score >-2.5 is a critical target for reducing fracture risk, and denosumab treatment can help women reach this goal.